(Total Views: 589)
Posted On: 04/23/2021 12:16:23 AM
Post# of 155727
“HIV, COVID and Oncology”
Serious indications. This is still such an undervalued stock IMO. I’m buying note this week at this point. I’m addicted to buying shares.
My questions is when is CD16 and CD17 going to get the show on the road!? Second wave or the real second wave sounds like it’s coming. It would be nice to get Leronlimab available......
Serious indications. This is still such an undervalued stock IMO. I’m buying note this week at this point. I’m addicted to buying shares.
My questions is when is CD16 and CD17 going to get the show on the road!? Second wave or the real second wave sounds like it’s coming. It would be nice to get Leronlimab available......
(2)
(0)
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
